• Busca persones
• Intranet

Grup de recerca translacional en neoplàsies hematològiques Blanca Espinet

Publicacions 2025 (11)

• Medina Á, Muntañola A, Crespo M, Ramírez Á^*, Hernández-Rivas JA^*, Abrisqueta-Costa P, Alcoceba M, Delgado J, de la Serna J, Espinet B, González M, Loscertales J, Serrano A, Terol MJ, Yáñez L, Bosch F, en nombre del Grupo Español de Leucemia Linfocítica Crónica (GELLC). Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma from Chronic Lymphocytic Leukemia Spanish Group (GELLC). Med Clin (Barc) 2025: (en Premsa).
  Cites:0
  Cites:0
• Rocha P^*, Bach R, Masfarre-Pinto L, Hernandez S, Navarro-Gorro N, Rossell A, Villanueva X, Giner M, Sánchez I, Galindo M, del Rey-Vergara R, Iñañez A, Sánchez-Espiridión B, Lu W, Acedo A, Berenguer-Molins P, Sánchez-Font A, Chalela R, Curull V, Taus A, Hardy-Werbin M, Sausen M, Georgiadis A, White J, Jackson JB, Moliner L, Clavé S, Bellosillo B, Rovira A, Wistuba I, Solis-Soto L, Perera J, Arriola E. Molecular and immunological features associated with long-term benefits in metastatic NSCLC patients undergoing immune checkpoint blockade. OncoImmunology 2025; 14(1): 2469377.
  Cites:0
  Cites:0
• Ruiz-Xivillé N^*, Morgades M, Blanco-Presas L, Costa D, Espinet B, Talavera E, Triviño E, Ortega M, Villamon E, Zamora L, Navarro JT, Arnan M, Vives S, Esteve J, Sierra J, Ribera JM, Granada I. Prognostic impact of cytogenetic alterations in newly diagnosed acute myeloid leukemia treated with risk-adapted protocols. Med Clin (Barc) 2025; 165(4): 107106.
• Thorvaldsdottir B, Mansouri L, Sutton LA, Nadeu-Prat F, Meggendorfer M, Parker H, Brieghel C, Laidou S, Moia R, Rossi D, Kotaskova J, Delgado J, Rodríguez-Vicente AE, Benito R, Rigolin GM, Bonfiglio S, Scarfò L, Mattsson M, Davis Z, Baliakas P, Rapado I, Miras F, Martínez-López J, de la Serna J, Hernández-Rivas JM, Larráyoz MJ, Calasanz MJ, Smedby KE, Espinet B, Puiggros A, Bullinger L, Bosch F, Tazón-Vega B, Baran-Marszak F, Oscier D, Nguyen-Khac F, Zenz T, Terol MJ, Cuneo A, Hernández-Sánchez M, Pospisilova S, Gaidano G, Niemann CU, Campo E, Strefford JC, Ghia P, Stamatopoulos K, Rosenquist R^*. ATM aberrations in chronic lymphocytic leukemia: del(11q) rather than ATM mutations is an adverse-prognostic biomarker. Leukemia 2025; 39(7): 1650-1660.
  Cites:0
  Cites:0
• Roncaglia E, Gaffo E, Calabretto G, Fürstenau M, Rogers KA, Baliakas P, Cui C, Miller C, Haferlach C, Plevova K, Oscier D, Davis Z, Nguyen-Khac F, Rigolin GM, Athanasiadou A, Baran-Marszak F, Valiente A, Terol MJ, Abrisqueta-Costa P, Espinet B, Puiggros A, Martines A, Bonaldi L, Mauro FR, Scarfò L, Chatzikonstantinou T, Tausch E, Kreuzer KA, Kater A, Bosch F, Doubek M, Panagiotidis P, Kalashnikova O, Frezzato F, Ruocco V, Orsi S, Salek K, Merlo R, Caregari A, Glogovitis I, Cellini A, Angotzi F, Serafin A, Yi S, Eichhorst B, Woyach JA, Cuneo A, Ghia P, Stamatopoulos K, Trentin L, Visentin A^*, Bortoluzzi S. Circular RNA signature of aggressive CLL with t(14;19)(q32;q13). An ERIC study. J Hematol Oncol 2025; 18(1): 74.
  Cites:1
  Cites:1
• Kanagal-Shamanna R^*, Puiggros A, Granada I, Raca G, Rack K, Mallo M, Dewaele B, Smith AC, Akkari Y, Levy B, Hasserjian RP, Cisneros A, Salido M, García-Manero G, Yang H, Iqbal MA, Kolhe R, Solé F, Espinet B^*. Integration of Optical Genome Mapping in the Cytogenomic and Molecular Work-Up of Hematological Malignancies: Expert Recommendations From the International Consortium for Optical Genome Mapping. Am J Hematol 2025; 100(6): 1029-1048.
  Cites:0
  Cites:0
• Papaleo NF, Molina-Alvarez A, Tapia G, Onieva R, Salido M, Lome-Maldonado C, Ara-Mancebo X, Puiggros A, Espinet B, Blazquez C, Fuertes D, Sánchez-González B, Yelamos J, Calvo X, Colomo L^*. Combined immunohistochemical profile CD10/LMO2/MYC is a useful tool to screen MYC rearrangements in aggressive large B-cell lymphomas. Virchows Arch 2025; 486(5): 951-959.
  Cites:0
  Cites:0
• Perucca A, Gómez-Llonin A, Benach OM, Hallopeau C, Rivas EI, Linares JL, Garrido M, Sallent A, Golde T, Colombelli J, Dalaka E, Linacero J, Cazorla M, Galan T, Pastor-Viel J, Badenas X, Recort-Bascuas A, Comerma L, Fernandez-Nogueira P, Rovira A, Roca-Cusachs P, Albanell J, Trepat X^*, Calon A^*, Labernadie A^*. Micro Immune Response On-chip (MIRO) models the tumour-stroma interface for immunotherapy testing. Nat Commun 2025; 16(1): 1279.
  Cites:4
  Cites:4
• Abril-Pérez C, Mansilla-Polo M^*, Escutia-Muñoz B, Sanmartín O, Garcés JR, Rodríguez-Prieto MA, Ruiz-Salas V, de Eusebio Murillo E, Miñano R, Gonzalez-Sixto B, Artola Igarza JL, Alfaro Rubio A, Redondo P, Delgado-Jiménez Y, Sánchez J, Allende Markixana I, Alonso-Pacheco ML, Garcia-Bracamonte B, De la Cueva-Dobao P, Navarro R, Ciudad-Blanco C, Carnero-González L, Vázquez-Veiga H, Cano-Martinez N, Serra-Guillén C, Vilarrasa E, Sánchez-Sambucety P, López-Estebaranz JL, Florez-Menéndez A, Martorell-Calatayud A, Gil P, Morales-Gordillo V, Toll A, Ocerin-Guerra I, Mayor Arenal M, Suarez Fernández R, Sainz-Gaspar L, Descalzo MA, García-Doval I, Botella-Estrada R, REGESMOHS (Registro Español de Cirugía de Mohs). Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study (REGESMOHS, Spanish registry of Mohs surgery). J Eur Acad Dermatol Venereol 2025; 39(2): 426-434.
  Cites:3
  Cites:3
• Ceravalls J^*, Pérez-Muñoz N, Sola MÁ, Gallardo F, Colomo L, Pujol RM. Asymptomatic evanescent plaques on the buttocks of an elderly woman. Int J Dermatol 2025; 64(1): 79-81.
  Cites:0
  Cites:0
• Hernández A, Rodríguez-Vida A, Cardona L, Qin M, Arpí O, Soria-Jiménez L, Menéndez S, Quimis F, Galindo M, Arriola E, Salido M, Juanpere N, Rojo F, Muntasell A, Albanell J, Rovira A, Bellmunt J^*. Enhancing immunotherapy through PD-L1 upregulation: the promising combination of anti-PD-L1 plus mTOR inhibitors. Mol Oncol 2025; 19(1): 151-172.
  Cites:4
  Cites:4